Physician profile
Maria E Ramirez
NPI 1447872007
$1,272.73
in general payments reported to CMS, 2019-2025
14 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $499 · 2023: $191 · 2024: $58.56 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $322.18 | 2021-2023 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $172.59 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.38 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $154.92 | 2021-2025 | Mounjaro, Trulicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.70 | 2021-2023 | Xifaxan, Trulance |
| Abbvie INC. | $86.21 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $85.87 | 2021-2023 | |
| Astrazeneca Pharmaceuticals Lp | $36.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $33.29 | 2021-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Amarin Pharma, INC. | $28.95 | 2021-2022 | |
| Integra Lifesciences Corporation | $22.94 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Organon LLC | $19.83 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $16.24 | 2022 | |
| Hologic Sales and Service, LLC | $15.19 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.